Joseph D. Mosca

Person

Ellicott City, MD, US

People

Patents Grantslast 30 patents

Information Patent Grant
Chronic pathogen-expressing cell lines
- Patent number 7,662,608
- Issue date Feb 16, 2010
- JDM Technologies, Inc.
- Joseph D. Mosca
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Grant
Production of “biological carriers” for induction of immune respons...
- Patent number 7,579,007
- Issue date Aug 25, 2009
- JDM Technologies, Inc.
- Joseph D. Mosca
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Grant
Uses of fibroblasts or supernatants from fibroblasts for the suppre...
- Patent number 7,491,388
- Issue date Feb 17, 2009
- Osiris Therapeutics, Inc.
- Kevin R. Mc Intosh
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Antigen presenting mesenchymal stem cells
- Patent number 7,101,704
- Issue date Sep 5, 2006
- Osiris Therapeutics, Inc.
- Joseph Mosca
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Grant
Uses for non-autologous mesenchymal stem cells
- Patent number 7,029,666
- Issue date Apr 18, 2006
- Osiris Therapeutics, Inc.
- Scott P. Bruder
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Grant
Mesenchymal stem cells for prevention and treatment of immune respo...
- Patent number 6,875,430
- Issue date Apr 5, 2005
- Osiris Therapeutics, Inc.
- Kevin R. McIntosh
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Grant
Mesenchymal stem cells as immunosuppressants
- Patent number 6,797,269
- Issue date Sep 28, 2004
- Osiris Therapeutics, Inc.
- Joseph D. Mosca
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Grant
Mesenchymal stem cells for prevention and treatment of immune respo...
- Patent number 6,368,636
- Issue date Apr 9, 2002
- Osiris Therapeutics, Inc.
- Kevin R. McIntosh
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Uses for non-autologous mesenchymal stem cells
- Patent number 6,355,239
- Issue date Mar 12, 2002
- Osiris Therapeutics, Inc.
- Scott P. Bruder
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Mesenchymal stem cells for prevention and treatment of immune respo...
- Patent number 6,328,960
- Issue date Dec 11, 2001
- Osiris Therapeutics, Inc.
- Kevin R. McIntosh
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Antigen presenting cells of the adipocyte lineage
- Patent number 6,149,906
- Issue date Nov 21, 2000
- Osiris Therapeutics, Inc.
- Joseph D. Mosca
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE

Patents Applicationslast 30 patents

Information Patent Application
Tumor-derived Biological Antigen Presenting Particles
- Publication number 20110262389
- Publication date Oct 27, 2011
- Joseph D. Mosca
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
Intraperitoneal Delivery of Genetically Engineered Mesenchymal Stem...
- Publication number 20110027241
- Publication date Feb 3, 2011
- Padmavathy Vanguri
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
Intraperitoneal Delivery of Genetically Engineered Mesenchymal Stem...
- Publication number 20110027237
- Publication date Feb 3, 2011
- Padmavathy Vanguri
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
Intraperitoneal Delivery of Genetically Engineered Mesenchymal Stem...
- Publication number 20100255111
- Publication date Oct 7, 2010
- OSIRIS THERAPEUTICS, INC.
- PADMAVATHY VANGURI
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
CHRONIC PATHOGEN-EXPRESSING CELL LINES
- Publication number 20100178302
- Publication date Jul 15, 2010
- JDM Technologies, Inc.
- Joseph D. Mosca
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
PRODUCTION OF BIOLOGICAL CARRIERS FOR INDUCTION OF IMMUNE RESPONSE...
- Publication number 20100015597
- Publication date Jan 21, 2010
- Joseph D. Mosca
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
Intraperitoneal Delivery Of Genetically Engineered Mesenchymal Stem...
- Publication number 20090257989
- Publication date Oct 15, 2009
- Padmavathy Vanguri
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
Intraperitoneal Delivery Of Genetically Engineered Mesenchymal Stem...
- Publication number 20090238802
- Publication date Sep 24, 2009
- Padmavathy Vanguri
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
Production of a protein delivery system for in vivo therapeutic tre...
- Publication number 20050175588
- Publication date Aug 11, 2005
- Joseph D Mosca
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
Chronic pathogen-expressing cell lines
- Publication number 20050074881
- Publication date Apr 7, 2005
- Joseph D. Mosca
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
Gp41 peptides and methods based thereon for inhibiting HIV fusion t...
- Publication number 20040137426
- Publication date Jul 15, 2004
- Pierre-Francois Serres
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
Production of "biological carriers" for induction of immune respons...
- Publication number 20040116367
- Publication date Jun 17, 2004
- Joseph D. Mosca
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
Intraperitoneal delivery of genetically engineered mesenchymal stem...
- Publication number 20040033217
- Publication date Feb 19, 2004
- Padmavathy Vanguri
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
Mesenchymal stem cells for prevention and treatment of immune respo...
- Publication number 20020085996
- Publication date Jul 4, 2002
- Kevin R. McIntosh
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Application
Uses for non-autologous mesenchymal stem cells
- Publication number 20020064519
- Publication date May 30, 2002
- Scott P. Bruder
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Application
MESENCHYMAL STEM CELLS AS IMMUNOSUPPRESSANTS
- Publication number 20020044923
- Publication date Apr 18, 2002
- JOSEPH D. MOSCA
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...

Joseph D. Mosca

Person

Patents Grantslast 30 patents

Chronic pathogen-expressing cell lines

Production of “biological carriers” for induction of immune respons...

Uses of fibroblasts or supernatants from fibroblasts for the suppre...

Antigen presenting mesenchymal stem cells

Uses for non-autologous mesenchymal stem cells

Mesenchymal stem cells for prevention and treatment of immune respo...

Mesenchymal stem cells as immunosuppressants

Mesenchymal stem cells for prevention and treatment of immune respo...

Uses for non-autologous mesenchymal stem cells

Mesenchymal stem cells for prevention and treatment of immune respo...

Antigen presenting cells of the adipocyte lineage

Patents Applicationslast 30 patents

Tumor-derived Biological Antigen Presenting Particles

Intraperitoneal Delivery of Genetically Engineered Mesenchymal Stem...

Intraperitoneal Delivery of Genetically Engineered Mesenchymal Stem...

Intraperitoneal Delivery of Genetically Engineered Mesenchymal Stem...

CHRONIC PATHOGEN-EXPRESSING CELL LINES

PRODUCTION OF BIOLOGICAL CARRIERS FOR INDUCTION OF IMMUNE RESPONSE...

Intraperitoneal Delivery Of Genetically Engineered Mesenchymal Stem...

Intraperitoneal Delivery Of Genetically Engineered Mesenchymal Stem...

Production of a protein delivery system for in vivo therapeutic tre...

Chronic pathogen-expressing cell lines

Gp41 peptides and methods based thereon for inhibiting HIV fusion t...

Production of "biological carriers" for induction of immune respons...

Intraperitoneal delivery of genetically engineered mesenchymal stem...

Mesenchymal stem cells for prevention and treatment of immune respo...

Uses for non-autologous mesenchymal stem cells

MESENCHYMAL STEM CELLS AS IMMUNOSUPPRESSANTS